According to ResMed's latest financial reports the company's current EPS (TTM) is $10.38. In 2022 the company made an earnings per share (EPS) of $9.30 an increase over its 2021 EPS that were of $6.03.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $9.99 | 7.36% |
2022 | $9.30 | 54.19% |
2021 | $6.03 | -25.88% |
2020 | $8.14 | 52.37% |
2019 | $5.34 | 0.63% |
2018 | $5.31 | 55.94% |
2017 | $3.40 | -12.17% |
2016 | $3.88 | -7.63% |
2015 | $4.20 | -0.4% |
2014 | $4.21 | 9.65% |
2013 | $3.84 | 12.32% |
2012 | $3.42 | -10.18% |
2011 | $3.81 | 58.6% |
2010 | $2.40 | 23.91% |
2009 | $1.94 | 44.65% |
2008 | $1.34 | 96.3% |
2007 | $0.68 | -41.3% |
2006 | $1.16 | 35.29% |
2005 | $0.86 | 9.68% |
2004 | $0.78 | 20% |
2003 | $0.65 | 27.05% |
2002 | $0.51 | 159.57% |
2001 | $0.20 | -43.37% |
2000 | $0.35 | 25.76% |
1999 | $0.28 | 45.05% |
1998 | $0.19 | 54.24% |
1997 | $0.12 | 28.26% |
1996 | $0.09690 |